Doctor sends warning

Micro-dosing Ozempic is gaining popularity among those seeking weight loss, especially as celebrities like Oprah Winfrey and Amy Schumer have publicly shared their use of the drug. Originally intended for treating type 2 diabetes, Ozempic contains semaglutide, which regulates appetite and is approved for weight loss under the brand name Wegovy. Despite Ozempic not being FDA-approved for weight loss, it has become widely used, with CNN reporting that one in eight Americans had tried Ozempic or similar GLP-1 drugs by last year.

One user, Madison Burgess, shared her experience of micro-dosing Ozempic due to the harsh side effects of the full dose, losing 60 pounds over two years. However, Dr. Natasha Yates has warned against this practice, citing a lack of research on its safety. While lower doses may cause fewer side effects, micro-dosing could lead to using expired medication, increasing the risk of infections. Dr. Yates emphasized that individuals should not attempt micro-dosing without medical supervision, as there are no formal guidelines and unmonitored use can be risky. The overall effectiveness of micro-dosing remains uncertain due to limited scientific testing.